Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 16 | 16 | 0 |
| Shares | 178.2K | 285.8K | +107.6K (+60.4%) |
| Value | $236.2K | $328.0K | +$91.8K (+38.9%) |
New holders (4)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 25,874 | $29.8K | 0.00% |
| Citadel Advisors LLC | 24,746 | $28.5K | 0.00% |
| 1620 Investment Advisors, Inc. | 3,600 | $4.14K | 0.00% |
| Bank of America Corp | 689 | $792 | 0.00% |
Sold out (4)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Virtu Financial LLC | 20,469 | $27.0K |
| Advisor Group Holdings, Inc. | 2,500 | $3.33K |
| Headlands Technologies LLC | 64 | $85 |
| Wells Fargo & Company | 11 | $15 |